Many serious conditions can present with vague or atypical symptoms, making early diagnosis challenging and highlighting the ...

TX45 APEX Phase 2 patient enrollment in PH-HFpEF is nearing completion with topline results anticipated in late Q4 2026 or early Q1 2027TX2100 advanced into Phase 1a healthy volunteer clinical trial ...

Commercialization of Palforzia, the first FDA-approved peanut allergy oral immunotherapy, will be discontinued at the end of ...

Detailed price information for Bausch & Lomb Corp (BLCO-N) from The Globe and Mail including charting and trades.

INSTI, Tenofovir-Free Regimen DOR/ISL Gains FDA Approval for HIV This fixed-dose, 2-drug combination is a once-daily, ...

BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections ...

Researchers noted growing evidence supporting an additional role for B vitamins.

Muscle pain can come from overuse, chronic illness, or nerve-related conditions, and it affects millions of people in daily ...

Through 120 weeks of follow-up, IMAAVY delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ ...

The landscape of medical education is shifting rapidly, with 2026 marking a pivotal year where artificial intelligence and virtual reality merge to create accessible, high-fidelity learning ...

Through 120 weeks of follow-up, nipocalimab delivered sustained clinical improvements and reductions in total IgG in antibody-positive adult patients including anti-AChR+ and anti-MuSK+ ...